ALKS

#1105
Alkermes plc - Ordinary Shares
42.6 9 USD
+6.89%
Setor: Cuidados de saúde
Base: USD
Moeda do lucro: USD
Faixa diária
42.19
42.83
Faixa anual
25.16
42.83
Mudança diária
+6.89%
Mudança mensal
+25.97%
Mudança em 6 meses
+45.70%
Mudança anual
+41.12%
Fechamento anterior
39.9 4
Open
42.3 3
Mínimo
42.1 9
High
42.8 3
Volume
829
Abrir gráfico completo Full chart

Financials

Visão geral Relatórios Estatísticas
Trimestral Ano
  • Market Capitalization 7.12 B
  • Employee 2 050
  • Founded 1987
  • CEO Richard F. PopsRichard F. Pops
  • Website www.alkermes.com
  • Headquarter Ireland
  • FIGI UNKNOWN
  • Industry Fabricantes de medicamentos - especializados e genéricos
Receita total
Lucro líquido
Lucro básico por ação
Dívida total
Fluxo de caixa livre
Caixa e equivalentes de caixa
Índice preço/lucro
19.57
Índice preço/fluxo de caixa
3.2

Alkermes plc - Ordinary Shares

Alkermes plc is a fully-integrated biopharmaceutical company that focuses on developing medicines for psychiatric and neurological disorders. The company was founded in 1987 by Michael Wall. In September 2011 Alkermes, Inc. merged with Elan Drug Technologies, the former drug formulation and manufacturing division of Élan Corporation, plc. The company is headquartered in Dublin, and has an R&D center in Waltham, Massachusetts, and a manufacturing facility in Wilmington, Ohio.

Notícias